RSV Vaccine
RSV
Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. Vaccines are available to protect older adults from severe RSV. Vaccines for pregnant people or monoclonal antibody products are available to protect infants and young children from severe RSV
Eligible patients for the programme include:
- Pregnant women over 28 weeks to help protect their newborn babies – please speak with your midwife
- Adults turning 75 years old on or after 1st September 2024
- Adults already 75 to 79 years on 1st September 2024
Adults remain eligible until the day before their 80th birthday (unless they turn 80 before the end of August 2025 in which case they are eligible until 31.8.25)
Appointments for administering this vaccine will be available from September with certain members of our nursing team.